Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study …

D Wilkins, AC Langedijk, RJ Lebbink… - The Lancet Infectious …, 2023 - thelancet.com
Background Nirsevimab is an extended half-life monoclonal antibody to the respiratory
syncytial virus (RSV) fusion protein that has been developed to protect infants for an entire …

Bibliometric structured review of tuberculosis in Nigeria

SA Olaleye, OS Balogun, F Adusei-Mensah - African Health Sciences, 2023 - ajol.info
Background: The tuberculosis burden is growing in Nigeria along with its population. For
example, Nigeria has the sixth highest TB burden globally, with an estimated 4.3 per cent …

[KNJIGA][B] Nigerian Healthcare System

JA Balogun - 2021 - Springer
The Western-style healthcare system was imported into the region now known as Nigeria
over 500 years ago, through the trans-Sahara trade routes by the European traders …

Tuberculosis care quality in urban Nigeria: A cross-sectional study of adherence to screening and treatment initiation guidelines in multi-cadre networks of private …

LA Rosapep, S Faye, B Johns… - PLOS Global Public …, 2022 - journals.plos.org
Nigeria has a high burden of tuberculosis (TB) and low case detection rates. Nigeria's large
private health sector footprint represents an untapped resource for combating the disease …

Engagement of private health care facilities in TB management in Lusaka district of Zambia: lessons learned and achievements

R Hambwalula, M Kagujje, I Mwaba, D Musonda… - BMC Public Health, 2024 - Springer
Background Globally, at least 3 million TB patients are missed every year. In Zambia, the TB
treatment coverage increased from 66% in 2020 to 92% in 2022. Involvement of all levels of …

Challenges in engaging the private sector for tuberculosis prevention and care in Nigeria: a mixed methods study

O Chijioke-Akaniro, S Onyemaechi, J Kuye… - BMJ open, 2023 - bmjopen.bmj.com
Objectives This study aimed to assess the practices of private practitioners regarding
tuberculosis (TB), and to ascertain factors related to the low contribution of private …

Public–Private Mix (PPM) for Tuberculosis (TB) in Urban Health Systems in Least Developed, Low Income and Lower-Middle-Income Countries and Territories–A …

AL Vidyasagaran, NT Siqueira, S Kakchapati, TF Hall… - medRxiv, 2024 - medrxiv.org
Objective To assess the impact of Public-Private Mix (PPM) models for Tuberculosis (TB)
diagnosis and treatment on health, process, and system outcomes within urban contexts of …

Exploration of the diversity of multi-drug resistant Mycobacterium tuberculosis complex in Lagos, Nigeria using WGS: Distribution of lineages, drug resistance patterns …

MNF Noorizhab, NZ Abidin, LK Teh, TH Tang… - Tuberculosis, 2023 - Elsevier
Multidrug-resistant (MDR) or extensively drug-resistant (XDR) Tuberculosis (TB) is a major
challenge to global TB control. Therefore, accurate tracing of in-country MDR-TB …

[HTML][HTML] The Role of Trust as a Driver of Private-Provider Participation in Disease Surveillance: Cross-Sectional Survey From Nigeria

EMH Mitchell, OA Adejumo… - JMIR Public Health …, 2024 - publichealth.jmir.org
Background: Recognition of the importance of valid, real-time knowledge of infectious
disease risk has renewed scrutiny into private providers' intentions, motives, and obstacles …

Tuberculosis treatment outcomes and associated factors at Alemgena Health Center, Sebeta, Oromia, Ethiopia

K Hayre, MK Takele, DJ Birri - Plos one, 2024 - journals.plos.org
Background Tuberculosis (TB) is a global public health problem. Evaluation of TB treatment
outcome enables health institutions to measure and improve the effectiveness of TB control …